In vitro antibacterial and time-kill assessment of crude methanolic stem bark extract of Acacia mearnsii de wild against bacteria in shigellosis

Molecules

Volumn 17, Issue 2, 2012, Pages 2103-2118

  Olajuyigbe, Olufunmiso Olusola ^a   Afolayan, Anthony Jide ^a  

^a UNIVERSITY OF FORT HARE   (South Africa)

Author keywords

A. mearnsii; Antibacterial; Methanolic extract; Shigellosis; Time kill

Indexed keywords

ANTIINFECTIVE AGENT; METHANOL; PLANT EXTRACT;

ACACIA; ARTICLE; BACTERIUM; BARK; CHEMISTRY; DRUG EFFECT; DRUG MIXTURE; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; PUBLIC HEALTH; SHIGELLOSIS; SOUTH AFRICA;

ACACIA; ANTI-BACTERIAL AGENTS; BACTERIA; COMPLEX MIXTURES; DYSENTERY, BACILLARY; METHANOL; MICROBIAL SENSITIVITY TESTS; PLANT BARK; PLANT EXTRACTS; PUBLIC HEALTH; SOUTH AFRICA;

EID: 84857574005     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17022103     Document Type: Article

References (101)

1. Bastos, F.C.; Loureiro, E.C. Antimicrobial Resistance of Shigella spp. isolated in the State of Pará, Brazil. Rev. Soc. Bras. Med. Trop. 2011, 44, 607-610.
2. Gupta, S.; Mishra, B.; Muralidharan, S.; Srinivasa, H. Ceftriaxone resistant Shigella flexneri, an emerging problem. Indian J. Med. Sci. 2010, 64, 553-556.
3. Huang, I.F.; Chiu, C.H.; Wang, M.H.; Wu, C.Y.; Hsieh, K.S.; Chiou, C.C. Outbreak of dysentery associated with Ceftriaxone-resistant Shigella sonnei: First report of Plasmid-Mediated CMY-2- Type AmpC ß-Lactamase resistance in S. sonnei. J. Clin. Microbiol. 2005, 43, 2608-2612. (Pubitemid 40827928)
4. Ashkenazi, S. Shigella infections in children: new insights. Semin. Pediatr. Infect. Dis. 2004, 15, 246-252. (Pubitemid 39371105)
5. Chattopadhyay, U.K.; Gupta, S.; Dutta, S. Search for shiga toxin producing Escherichia coli (STEC) including 0157: H7 strains in and around Kolkata. Indian J. Med. Microbiol. 2003, 21, 17-20. (Pubitemid 37038684)
6. Tayung, K.; Kar, A. Antimicrobial activity of Thalictrum javanicum root extract against certain human pathogen. J. Curr. Sci. 2005, 7, 341-345.
7. Barman, S.; Saha, D.R.; Ramamurthy, T.; Koley, H. Development of a new guinea-pig model of shigellosis. FEMS Immunol. Med. Mic. 2011, 62, 304-314.
8. Vinh, H.; Anh, V.T.; Anh, N.D.; Campbell, J.I.; Hoang, N.V.; Nga, T.V.; Nhu, N.T.; Minh, P.V.; Thuy, C.T.; Duy, P.T.; et al. A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children. PLoS Negl. Trop. Dis. 2011, 5, e1264.
9. Bangtrakulnonth, A.; Vieira, A.R.; Lo Fo Wong, D.M.; Pornreongwong, S.; Pulsrikarn, C.; Sawanpanyalert, P.; Hendriksen, R.S.; Aarestrup, F.M. Shigella from humans in Thailand during 1993 to 2006: Spatial-time trends in species and serotype distribution. Foodborne Pathog. Dis. 2008, 5, 773-784.
10. Riley, L.W.; Remis, R.S.; Helgerson, S.D.; McGee, H.B.; Wells, J.G.; Davis, B.R.; Bebert, R.J.; Olcott, E.S.; Johnsosn, L.M.; Hargrett, N.T.; et al. Haemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 1983, 308, 681-685. (Pubitemid 13157770)
11. Kaper, J.B.; Nataro, J.P.; Mobley, H.L. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2004, 2, 123-140. (Pubitemid 39490066)
12. Ram, P.K.; Crump, J.A.; Gupta, S.K.; Miller, M.A.; Mintz, E.D. Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005. Epidemiol. Infect. 2008, 136, 577-603. (Pubitemid 351472169)
13. Kotloff, K.L.; Winickoff, J.P.; Ivanoff B, Clemens, J.D.; Swerdlow, D.L.; Sansonetti P.J.; Adak, G.K.; Levine, M.M. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Organ. 1999, 77, 651-666. (Pubitemid 29446617)
14. Niyogi, S.K. Shigellosis. J. Microbiol. 2005, 43, 133-143. (Pubitemid 40720615)
15. Diarrhoeal disease due to Shigella disease. In Vaccines, Immunization and Biologicals; World Health Organization: Geneva, Switzerland, 1998; pp. 1-5.
16. MoezArdalan, K.; Zali, M.R.; Soltan-Dallal, M.M.; Hemami, M.R.; Salmanzadeh-Ahrabi, S. Prevalence and pattern of antimicrobial resistance of Shigella species among patients with acute diarrhoea in Karaj, Tehran, Iran. J. Health Popul. Nutr. 2003, 21, 6-102.
17. Lee, H.; Kotloff, K.; Chukaserm, P.; Samosornsuk, S.; Chompook, P.; Deen, J.L.; Von Seidlein, L.; Clemens, J.D.; Wanpen, C. Shigellosis remains an important problem in children less than 5 years of age in Thailand. Epidemiol. Infect. 2005, 133, 469-474. (Pubitemid 40867683)
18. Wang, X.Y.; Tao, F.; Xiao, D.; Lee, H.; Deen, J.; Gong, J.; Zhao, Y.; Zhou, W.; Li, W.; Shen, B.; et al. Trend and disease burden of bacillary dysentery in china (1991-2000). Bull. World Health Organ. 2006, 84, 561-568.
19. Wang, X.Y.; Du, L.; Von Seidlein, L.; Xu, Z.Y.; Zhang, Y.L.; Hao, Z.Y.; Han, O.P.; Ma, J.C.; Lee, H.J.; Ali, M.; et al. Occurrence of shigellosis in the young and elderly in rural China: results of a 12-month population-based surveillance study. Am. J. Trop. Med. Hyg. 2005, 73, 416-422. (Pubitemid 41278722)
20. Alam, S.; Bhatnagar, S. Current status of anti-diarrheal and anti-secretory drugs in the management of acute childhood diarrhoea. Indian J. Pediatr. 2006, 73, 693-696. (Pubitemid 44319429)
21. Seol, S.Y.; Kim, Y.T.; Jeong, Y.S.; Oh, J.Y.; Kang, H.Y.; Moon, D.C.; Kim, J.; Lee, Y.C.; Cho, D.K.; Lee, J.C. Molecular characterization of antimicrobial resistance in Shigella sonnei isolates in Korea. J. Med. Microbiol. 2006, 55, 871-877. (Pubitemid 43974693)
22. von Seidlein, L.; Kim, D.R.; Ali, M.; Lee, H.; Wang, X.; Thiem, V.D.; Canh do, G.; Chaicumpa, W.; Agtini, M.D.; Hossain, A.; et al. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med. 2006, 3, e353.
23. Huq, I.; Alam, A.K.; Morris, G.K.; Wathen, G.; Merson, M. Foodborne outbreak of shigellosis caused by an unusual Shigella strain. J. Clin. Microbiol. 1980, 11, 337-339. (Pubitemid 10150265)
24. CDCP-Centers for Disease Control and Prevention. Shigella. Annual summary. US Department of Health and Human Services: Atlanta, GA, USA, 2002.
25. DuPont, H.L.; Formal, S.B.; Hornick, R.B.; Snyder, M.J.; Libonati, J.P.; Sheahan, D.; LaBrec, E.H.; Kalas, J.P. Pathogenesis of Escherichia coli diarrhea. N. Engl. J. Med. 1971, 285, 1-9.
26. Hale, T.L. Bacillary dysentery. In Topley and Wilson's Microbiology and Microbial Infections, Hansler, W.J., Shuman, M., Eds.; Arnold: London, UK, 1998; pp. 479-493.
27. Parsot, C.; Ageron, E.; Penno, C.; Mavris, M.; Jamoussi, K.; d'Hauteville, H.; Sansonetti, P.; Demers, B. A secreted anti-activator, OspD1, and its chaperone, Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri. Mol. Microbiol. 2005, 56, 1627-1635. (Pubitemid 40780656)
28. Grais, R.F.; Conlan, A.J.K.; Ferrari, M.J.; Djibo, A.; Le Menach, A.; Bjørnstad, O.N.; Grenfell, B.T. Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger. J. R. Soc. Interface 2008, 5, 67-74. (Pubitemid 350159192)
29. Mathur, R.; Mathur, Y.N.; Verma, S.D. An outbreak of shigellosis in central India: higher death rate in post-measles shigellosis. J. Diarrhoeal Dis. Res. 1989, 7, 28-29.
30. Mitra, A.K.; Alvarez, J.O.; Wahed, M.A.; Fuchs, G.J.; Stephensen, C.B. Predictors of serum retinol in children with shigellosis. Am. J. Clin. Nutr. 1998, 68, 1088-1094. (Pubitemid 28493971)
31. Victora, C.G.; Bryce, J.; Fontaine, O.; Monasch, R. Reducing deaths from diarrhoea through oral rehydration therapy. Bull. World Health Organ. 2000, 78, 1246-1255.
32. Lev, E. Ethno-diversity within current ethno-pharmacology as part of Israeli traditional medicine-A review. J. Ethnobiol. Ethnomed. 2006, 2, 4.
33. Hussain, K.; Shahazad, A.; Hussain, S.Z. An ethnobotanical survey of important wild medicinal plants of Hattar district Haripur, Pakistan. Ethnobot. Leafl. 2008, 12, 29-35.
34. Sheldon, J.W.; Balick, M.J.; Laird, S.A. Medicinal plants: can utilization and conservation coexist? Advances in Economic Botany. Econ. Bot. 1997, 12, 1-104.
35. Tene, V.; Malag, O.; Finzi, P.V.; Vidari, G.; Armijos, C.; Zaragoza, T. An ethnobotanical survey of medicinal plants used in Loja and Zamora-Chinchipe, Ecuador. J. Ethnopharmacol. 2007, 111, 63-81. (Pubitemid 46482884)
36. Hack, S.K. Do not put too much value on conventional medicine. J. Ethnopharmacol. 2006, 100, 37-39.
37. Sharma, P.P.; Mujundar, A.M. Traditional knowledge on plants from Toranmal Plateau of Maharastra. Indian J. Tradit. Know. 2003, 2, 292-296.
38. Cos, P.; Hermans, N.; De Bruyne, T.; Apers, S.; Sindambiwe, J.B.; Berghe, D.V.; Pieters, L.; Vlietinkck, A.J. Further evaluation of Rwandan medicinal plant extracts for their antimicrobial and antiviral activities. J. Ethnopharmacol. 2002, 79, 155-163. (Pubitemid 34136945)
39. Muschietti, L.; Derita, M.; Sülsen, V.; Muñoz, J.D.; Ferraro, G.; Zacchino; S.; Martino, V. In vitro antifungal assay of traditional Argentine medicinal plants. J. Ethnopharmacol. 2005, 102, 233-238. (Pubitemid 41483564)
40. Wannissorn, B.; Jarikasem, S.; Siriwangchai, T.; Thubthimthed, S. Antibacterial properties of essential oils from Thai medicinal plants. Fitoterapia 2005, 76, 233-236. (Pubitemid 40326974)
41. Olajuyigbe, O.O.; Babalola, A.E.; Afolayan, A.J. Antibacterial and phytochemical screening of crude ethanolic extracts of Waltheria indica Linn. Afr. J. Microbiol. Res. 2011, 5, 3760-3764.
42. Elisabetsky, E.; Amadar, T.A.; Albuquerque, R.R.; Nunes, D.S.; Carvalho, Ado, C. Analgesic activity of Psychotria colorata (Willd Ext. & S) Muell. Arg. alkaloid. J. Ethnopharmcol. 1995, 48, 77-83.
43. Patwardhan, B.; Warude, D.; Pushpangadan, P.; Bhatt, N. Ayurveda and traditional Chinese medicine: A comparative overview. Evid.-Based Compl. Alt. 2005, 2, 465-473. (Pubitemid 41752482)
44. Latz, P. Bushfires and Bushtuckers: Aboriginal Plant Use in Central Australia; IAD Press: Alice Springs, Australia, 2001.
45. Thomson, L.A.J.; Turnbull, J.W.; Maslin, B.R. The utilization of Australian species of Acacia, with particular reference to those of the subtropical dry zone. J. Arid. Environ. 1994, 27, 279-295. (Pubitemid 2101664)
46. Lithgow, M.G. 60 Wattles of the Chinchilla and Murilla Shires; Private publication: Chinchilla, Australia, 1997.
47. Pankey, G.A.; Sabath, L.D. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram positive bacterial infections. Clin. Infect. Dis. 2004, 38, 864-870. (Pubitemid 38387236)
48. Sanders, C.C.; Sanders, W.E., Jr. β-Lactamase resistance in gram-negative bacteria: global trends and clinical impact. Clin. Infect. Dis. 1992, 15, 824-839.
49. Fernandez, G.M.L.; Ramos, J.M.; Marrero, J.; Cuenca, M.; Fernandez, R.R.; de Gorgolas, M. Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of beta-lactam resistance on mortality. Int. J. Infect. Dis. 2003, 7, 46-52. (Pubitemid 36358876)
50. Ako-Nai, A.K.; Ikem, I.C.; Aziba, A.; Ajayi, A.A.; Onipede, O.A. Bacteriological examination of chronic osteomyelitis cases in Ile-Ife, South Western Nigeria. Afr. J. Clin. Exp. Microbiol. 2003, 4, 41-51.
51. Oliveira, D.C.; Tomasz, A.; de Lencastre, H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin resistant Staphylococcus aureus. Lancet Infect. Dis. 2002, 2,180-189. (Pubitemid 34462453)
52. Pankey, G.A.; Sabath, L.D. Clinical Relevance of Bacteriostatic versus Bactericidal mechanisms of action in the treatment of Gram positive bacterial infections. Clin. Infect. Dis. 2004, 38, 864-870. (Pubitemid 38387236)
53. Doit, C.; Barre, J.; Cohen, R.; Bonacorsi, S.; Bourrillon, A.; Bingen, E.H. Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin. Antimicrob. Agents Chemother. 1997, 41, 2050-2052. (Pubitemid 27383258)
54. Friedland, I.R.; Klugman, K.P. Cerebrospinal fluid bactericidal activity against cephalosporinresistant Streptococcus pneumoniae in children with meningitis treated with high-dose cefotaxime. Antimicrob. Agents Chemother. 1997, 41, 1888-1891. (Pubitemid 27383222)
55. Sculier, J.P.; Klastersky, J. Significance of serum bactericidal activity in Gram negative bacillary bacteremia in patients with and without granulocytopenia. Am. J. Med. 1984, 76, 429-435. (Pubitemid 14159554)
56. Peterson, L.R.; Shanholtzer, C.J. Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance. Clin. Microbiol. Rev. 1992, 5, 420-432.
57. Methods for determining bactericidal activity of antimicrobial agents; Approved guideline M26-A; National Committee for Clinical Laboratory Standards: Wayne, PA, USA, 1998.
58. Karaman, I.; Sahin, F.; Gulluce, M.; Ogutcu, H.; Sngul, M.; Adiguzel, A. Antimicrobial activity of aqueous and methanol extracts of Juniperus oxycedrus L. J. Ethnopharmacol. 2003, 85, 231-235. (Pubitemid 36294138)
59. Eloff, J.N. Which extractant should be used for the screening and isolation of antimicrobial components from plants? J. Ethnopharmacol. 1998, 60, 1-8. (Pubitemid 28098334)
60. Gatsing, D.; Nkeugoauapi, C.F.N.; Nkah, B.F.N.; Kuiate, J.R.; Tchouanguep, F.M. Antibacterial activity, bioavailability and acute toxicity evaluation of the leaf extract of Alchornea cordifolia (Euphorbiaceae). Int. J. Pharmacol. 2010, 6, 173-182.
61. Carbonnelle, B.; Denis, F.; Marmonier, A.; Pinon, G.; Vague, R. Bacteriologie médicale: Techniques usuelles; SIMEP: Paris, France, 1987; pp. 228-282.
62. Mims, C.A.; Playfair, J.H.L.; Roitt, I.M.; Wakelin, D.; Williams, R. Antimicrobials and chemotherapy. Med. Microbiol. Rev. 1993, 35, 1-34.
63. Haslam, E. Plant Polyphenols; Cambridge University Press: Cambridge, NY, USA, 1989.
64. Gajendiran, N.; Mahadevan, A. Utilization of catechin by Rhizobium sp. Plant Soil 1990, 108, 263-266.
65. Olajuyigbe, O.O.; Afolayan, A.J. Phytochemical assessment and antioxidant activities of alcoholic and aqueous extracts of Acacia mearnsii De Wild. Int. J. Pharmacol. 2011, 7, 856-861.
66. Doss, A.; Mubarack, H.M.; Dhanabalan, R. Pharmacological importance of Solanum trilobatum. Indian J. Sci. Technol. 2009, 2, 41-43.
67. Faizi, S.; Khan, R.A.; Azher, S.; Khan. S.A.; Tauseef Ahmad, S.A. New antimicrobial alkaloids from the roots of Polyalthia longifolia var. pendula. Planta Med. 2003, 69, 350-355. (Pubitemid 36578002)
68. Funatogawa, K.; Hayashi, S.; Shimomura, H.; Yoshida, T.; Hatano, T.; Ito H.; Hirai, Y. Antibacterial activity of hydrolyzable tannins derived from medicinal plants against Helicobacter pylori. Microbiol. Immunol. 2004, 48, 251-261. (Pubitemid 38508665)
69. Pepeljnjak, S.; Kalodera, Z.; Zoyko, M. Antimicrobial activity of flavonoids from Pelargonium radula (Cav.) L'Herit. Acta Pharmaceut. 2005, 55, 431-435. (Pubitemid 41820305)
70. Mandalari, G.; Bennett, R.N.; Bisignano, G.; Tombetta, D.; Saija, A.; Faulds, C.B.; Gasson, M.J.; Narbad, A. Antimicrobial activity of flavonoids extracted from bergamot (Citrus bergamia Risso) peel, a byproduct of the essential oil industry. J. Appl. Microbiol. 2007, 103, 2056-2064. (Pubitemid 350191155)
71. Avato, P.; Bucci, R.; Tava, A.; Vitali, C.; Rosato, A.; Bialy, Z.; Jurzysta, M. Antimicrobial activity of saponins from Medicago sp.: Structure-activity relationship. Phytother. Res. 2006, 20, 454-457. (Pubitemid 43953397)
72. Baharaminejad, S.; Asenstorfer, R.E.; Riley, I.T.; Schultz, C.J. Analysis of the antimicrobial activity of flavonoids and saponins isolated from the shoots of Oats (Avena sativa L.). J. Phytopathol. 2007, 156, 1-7. (Pubitemid 350264789)
73. Yao, J.; Moellering, R. Antibacterial agents. In Manual of Clinical Microbiology; Murray, P., Baron, E., Pfaller, M., Tenover, F., Yolken, R., Eds.; ASM Press: Washington, DC, USA, 1995; pp. 1281-1290.
74. Yani, V.V.; Oyedeji, O.A.; Grierson, D.S.; Afolayan, A.J. Chemical analysis and antimicrobial activity of essential oil extracted from Helichrysum aureonitens. S. Afr. J. Bot. 2005, 71, 239-241.
75. Sofidiya, M.O.; Odukoya, O.A.; Afolayan, A.J.; Familoni, O.B. Phenolic contents, antioxidant and antibacterial activities of Hymenocardia acida. Nat. Prod. Res. 2009, 23, 168-177.
76. Afolayan, A.J.; Ashafa, A.O.T. Chemical composition and antimicrobial activity of the essential oil from Chrysocoma ciliate L. leaves. J. Med. Plants Res. 2009, 3, 390-394.
77. Adwan, K.; Abu-Hasan, N. Gentamicin resistance in clinical strains of Enterobacteriaceae associated with reduced gentamicin uptake. Folia Microbiol. 1998, 43, 438-440. (Pubitemid 128441326)
78. Puupponen-Pimia, R.; Nohynek, L.; Alakomi, H.L.; Oksman-Caldentey, K.M. Bioactive berry compounds- novel tools against human pathogens. Appl. Microbiol. Biotechnol. 2004, 67, 8-18. (Pubitemid 40543908)
79. Min, B.R.; Barry, T.N.; Attwood, G.T.; McNabb, W.C. The effect of condensed tannins on the nutrition and health of ruminants fed fresh temperate forages: a review. Anim. Feed Sci. Tech. 2003, 106, 3-19. (Pubitemid 36572823)
80. Field, J.A.; Lettinga, G. Toxicity of tannic compounds to microorganisms. Plants Polyphenols: Synthesis, Properties, Significance. Basic Life Sci. 1992, 59, 673-692.
81. Viljoen, A.; Van Vuuren, S.; Ernest, E.; Klepser, M.; Demirci, B.; Basser, H.; Van Wyk, B.E. Osmitopsis asteriscoides (Asteraceae)-the antimicrobial and essential oil composition of Cape-Dutch remedy. J. Ethnopharmacol. 2003, 88, 137-143. (Pubitemid 37083438)
82. Erasto, P.; Bojase-Moleta, G.; Majinda, R.R.T. Antimicrobial and antioxidant flavonoids from the roots wood of Bolusathus spesiosus. Phytochemistry 2004, 65, 875-880. (Pubitemid 38471764)
83. Basri, D.F.; Fan, S.H. The potential of aqueous and acetone extracts of galls of Queercus infectoria as antibacterial agents. Indian J. Pharmacol. 2005, 37, 26-29. (Pubitemid 40239138)
84. European Committee for Antimicrobial Susceptibility Testing (EUCAST). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin. Micro. Infect. 2000, 6, 509-515.
85. Cheesbrough, M. Medical Laboratory Manual for Tropical Countries, ELBS ed.; Tropical health technology publications and Butterworth-Heinemann Ltd: Cambridge, UK, 2002; Volume 2, pp. 2-392.
86. Bauer, A.W.; Kirby, W.M. Sherris, J.C.; Truck, M. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 1966, 45, 493-496.
87. Wikler, M.A. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement; Part M2-A9. M100-S17; C.L.S.I. (Clinical and Laboratory Standard Institute): Pennsylvania, PA, USA, 2007.
88. Wikler, M.A. Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement; M100-S18; C.L.S.I. (Clinical and Laboratory Standard Institute): Pennsylvania, PA, USA, 2008; Volume 28, Issue 1, pp. 46-52.
89. Carson, C.F.; Hammer, K.A.; Riley, T.V. Broth micro-dilution method for determination of susceptibility of Escherichia coli and Staphylococcus aureus to the essential oil of Malaleuca alterifolia (Tea tree oil). Microbios 1995, 82, 181-185.
90. Iwaki, K.; Koya-Miyata, S.; Kohno, K.; Ushio, S.; Fukuda, S. Antimicrobial activity of Polygonum tintorium Lour: Extract against oral pathogenic bacteria. Nat. Med. 2006, 53, 72-79.
91. Khan, A.; Rhaman, M.; Islam, S. Antibacterial, antifungal and cytotoxic activities of Tuberous Roots of Amorphophallus campanulatus. Turk. J. Biol. 2007, 31, 167-172. (Pubitemid 47605813)
92. Shanholtzer, C.J.; Peterson, L.R.; Mohn, M.L.; Moody, J.A.; Gerding, D.N. MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques. Antimicrob. Agents Chemother. 1984, 26, 214-219. (Pubitemid 14050230)
93. Gerding, D.N.; Peterson, L.R.; Moody, J.A.; Fasching, C.E. Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits. J. Antimicrob. Chemother. 1985, 15 (Suppl. A), 207-219. (Pubitemid 15079566)
94. Bamberger, D.M.; Peterson, L.R.; Gerding, D.N.; Moody, J.A.; Fasching, C.E. Ciprofloxacin, azlocillin, ceftizoxime, and amikacin alone and in combination against Gram negative bacilli in an infected chamber model. J. Antimicrob. Chemother. 1986, 18, 51-63. (Pubitemid 16070369)
95. Moody, J.A.; Fasching, C.E.; Peterson, L.R.; Gerding, D.N. Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae. Diagn. Microbiol. Infect. Dis. 1987, 6, 59-67. (Pubitemid 17023710)
96. Fasching, C.E.; Peterson, L.R.; Moody, J.A.; Sinn, L.M.; Gerding, D.N. Treatment evaluation of experimental staphylococcal infections comparing β-lactam, lipopeptide, and glycopeptide antimicrobial therapy. J. Lab. Clin. Med. 1990, 116, 697-706. (Pubitemid 20378811)
97. Irkin, R.; Korukluoglu, M. Control of Aspergillus niger with garlic, onion and leek extracts. Afr. J. Biotechnol. 2007, 6, 384-387. (Pubitemid 46340018)
98. Eliopoulos, G.M.; Eliopoulos, C.T. Antibiotic combinations: should they be tested? Clin. Microbiol. Rev. 1988, 1, 139-156.
99. Eliopoulos, G.M.; Moellering, R.C. Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 4th ed.; Lorain, V., Ed.; The Williams & Wilkins Co.: Baltimore, MD, USA, 1996, 330-396.
100. Cruishank, R.; Duguid, J.P.; Marmion, B.P.; Swain, R.H.A. Medical Microbiology. The Practice of Medical Microbiology, 12th ed.; Churchill Livingstone: London, UK, 1975.
101. Pankuch, G.A.; Jacobs, M.R.; Appelbaum, P.C. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrob. Agents Chemother. 1994, 38, 2065-2072. (Pubitemid 24278802)